{
  "trial_id": "NCT00381940",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, stage of disease, histological subtype, performance status (Karnofsky or Lansky), life expectancy, absolute neutrophil count, platelet count, hemoglobin level, creatinine level, creatinine clearance or glomerular filtration rate, AST level, ALT level, bilirubin level, shortening fraction by echocardiogram, left ventricular ejection fraction (LVEF), presence of seizure disorder, CNS toxicity grade, presence of serious intercurrent illnesses, hypersensitivity to study drugs, peripheral neuropathy grade, pregnancy status, prior chemotherapy history, prior investigational drug use, concurrent medication use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "stage of disease",
        "histological subtype",
        "performance status (Karnofsky or Lansky)",
        "life expectancy",
        "absolute neutrophil count",
        "platelet count",
        "hemoglobin level",
        "creatinine level",
        "creatinine clearance or glomerular filtration rate",
        "AST level",
        "ALT level",
        "bilirubin level",
        "shortening fraction by echocardiogram",
        "left ventricular ejection fraction (LVEF)",
        "presence of seizure disorder",
        "CNS toxicity grade",
        "presence of serious intercurrent illnesses",
        "hypersensitivity to study drugs",
        "peripheral neuropathy grade",
        "pregnancy status",
        "prior chemotherapy history",
        "prior investigational drug use",
        "concurrent medication use"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Disease Stage, Histological Subtype, Performance Status, Absolute Neutrophil Count, Platelet Count, Hemoglobin, Creatinine, Creatinine Clearance, AST, ALT, Bilirubin, Left Ventricular Ejection Fraction (LVEF), Seizure Disorder Status, CNS Toxicity Grade,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Disease Stage",
        "Histological Subtype",
        "Performance Status",
        "Absolute Neutrophil Count",
        "Platelet Count",
        "Hemoglobin",
        "Creatinine",
        "Creatinine Clearance",
        "AST",
        "ALT",
        "Bilirubin",
        "Left Ventricular Ejection Fraction (LVEF)",
        "Seizure Disorder Status",
        "CNS Toxicity Grade"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Karnofsky Performance Status, Lanksy Performance Status, Histology, Stage of Disease, Number of Prior Relapses, Prior Therapy, Time from Initial Diagnosis to Relapse, Time from Last Therapy to Relapse, Presence of B Symptoms, Presence of Extranodal Disease, Presence of Bulky Disease, Absolute Neutrophil Count, Platelet Count, Hemoglobin, Creatinine, Creatinine Clearance, AST, ALT, Bilirubin, Shortening Fraction, LVEF.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Status",
        "Lanksy Performance Status",
        "Histology",
        "Stage of Disease",
        "Number of Prior Relapses",
        "Prior Therapy",
        "Time from Initial Diagnosis to Relapse",
        "Time from Last Therapy to Relapse",
        "Presence of B Symptoms",
        "Presence of Extranodal Disease",
        "Presence of Bulky Disease",
        "Absolute Neutrophil Count",
        "Platelet Count",
        "Hemoglobin",
        "Creatinine",
        "Creatinine Clearance",
        "AST",
        "ALT",
        "Bilirubin",
        "Shortening Fraction",
        "LVEF"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "age, sex, race, ethnicity, Karnofsky performance status, Lansky performance status, histological subtype of Hodgkin's lymphoma, stage of disease, presence of B symptoms, number of prior chemotherapy regimens, time since last prior therapy, presence of extranodal involvement, presence of bulky disease, serum lactate dehydrogenase level, absolute neutrophil count, platelet count, hemoglobin level, creatinine level, creatinine clearance, aspartate aminotransferase level, alanine aminotransferase level, bilirubin level, shortening fraction by echocardiogram, left ventricular ejection fraction by gated radionuclide study.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Karnofsky performance status",
        "Lansky performance status",
        "histological subtype of Hodgkin's lymphoma",
        "stage of disease",
        "presence of B symptoms",
        "number of prior chemotherapy regimens",
        "time since last prior therapy",
        "presence of extranodal involvement",
        "presence of bulky disease",
        "serum lactate dehydrogenase level",
        "absolute neutrophil count",
        "platelet count",
        "hemoglobin level",
        "creatinine level",
        "creatinine clearance",
        "aspartate aminotransferase level",
        "alanine aminotransferase level",
        "bilirubin level",
        "shortening fraction by echocardiogram",
        "left ventricular ejection fraction by gated radionuclide study"
      ]
    }
  }
}